Ogawa-Yamanaka Stem Cell Prize

Stem cell pioneer Masayo Takahashi (高橋 政代) leaves RIKEN

Masayo-Takahashi

In a surprise, Dr. Masayo Takahashi has announced that she has left RIKEN. Takahashi indicates she will be new President of a company called Vision Care, Inc. as part of the Kobe Eye Center. I’ve pasted a picture of Takahashi’s Tweet with translation more toward the bottom of the post. A big thanks to Piero …

Stem cell pioneer Masayo Takahashi (高橋 政代) leaves RIKEN Read More »

Stem cell movers and shakers early 2018

stem-cell-movers-and-shakers

Today’s piece is a stem cell movers and shakers post about individuals who have gotten awards, made moves, or otherwise made news recently. In some cases I’ve included relevant embedded tweets announcing the news. In case you’re wondering, the image at right is my attempt last year to make a graphic design that reflect both …

Stem cell movers and shakers early 2018 Read More »

Stem Cell Person of the Year Award 2015: Nominations Open

Logo3

It’s time for The Niche 4th annual Stem Cell Person of the Year Award process to start. Please send me your nominations for the person you think had the biggest positive impact in the stem cell and regenerative medicine world in 2015. This award is unique in a number of ways. For example, anyone in …

Stem Cell Person of the Year Award 2015: Nominations Open Read More »

Masayo Takahashi (高橋 政代) Receives Ogawa-Yamanaka Stem Cell Prize

Masayo-Takahashi

The winner of the inaugural Ogawa-Yamanaka Prize is Masayo Takahashi, MD, PhD. According to the Gladstone Institute press release, “Dr. Takahashi was awarded the prize for her trailblazing work leading the first clinical trial to use induced pluripotent stem (iPS) cells in humans.” The prize, including a $150,000 cash award, will be given at a ceremony …

Masayo Takahashi (高橋 政代) Receives Ogawa-Yamanaka Stem Cell Prize Read More »

Stem cell good news briefs: TiGenix, Asterias, CIRM, Awards, & More

TiGenix

There’s a growing stream of stem cell good news of late. Stem cell biotech, TiGenix, reported encouraging Phase 3 allogeneic results on stem cells. A big milestone. I can’t wait to see the actual data. Its product, Cx601, has so far been safe and effective for perianal fistulas in Crohn’s disease. See more from Alexey on this. CIRM has funded the largest …

Stem cell good news briefs: TiGenix, Asterias, CIRM, Awards, & More Read More »